Innate Pharma S.A. (IPHYF)
Market Closed
10 Aug, 20:00
$
1. 65
0
0%
$
- Market Cap
- P/E Ratio
- Div Yield
200 Volume
- Eps
$ 1.65
Previous Close Want to track IPHYF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | 0.15 |
| | | - | 0.16 |
| | | - | - |
| | | - | - |
| | | - | 0.01 |
| | | - | 0.01 |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
IPHYF Earnings Reports FAQ
What is the earnings per share (EPS) for IPHYF?
EPS data for IPHYF is currently not available, as Innate Pharma S.A has not reported recent earnings.
What is the company's earnings growth rate?
Over the past 12 years, the earnings growth rate has been approximately 1,303.74%, reflecting the IPHYF's performance and OTC PINK market conditions.
When is the next earnings release date?
Innate Pharma S.A has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Innate Pharma S.A are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for IPHYF at this time, as Innate Pharma S.A has no recent EPS data to calculate it.
